BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 26208532)

  • 1. Multimodality imaging of bilateral pheochromocytoma. A case report.
    Paladino NC; Lowery A; Guérin C; Taïeb D; Sebag F
    Ann Ital Chir; 2015 Jun; 86(ePub):. PubMed ID: 26208532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 6-18F-fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to 123I-metaiodobenzyl-guanidine scintigraphy in the detection of extraadrenal and hereditary pheochromocytomas and paragangliomas: correlation with vesicular monoamine transporter expression.
    Fottner C; Helisch A; Anlauf M; Rossmann H; Musholt TJ; Kreft A; Schadmand-Fischer S; Bartenstein P; Lackner KJ; Klöppel G; Schreckenberger M; Weber MM
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2800-10. PubMed ID: 20371665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 123I-MIBG, 18F-DOPA and 18F-FDG in a patient with MEN2 syndrome and recurrent pheochromocytoma.
    Cuenca-Cuenca JI; Marín-Oyaga VA; Borrego-Dorado I; Navarro-González E; Martos-Martínez JM; Vázquez-Albertino R
    Rev Esp Med Nucl Imagen Mol; 2013; 32(4):263-5. PubMed ID: 23434017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of pheochromocytoma with negative MIBG scintigraphy, PET-CT and genetic tests (VHL included) and a rare case of post-operative erectile dysfunction.
    Defeudis G; Fioriti E; Palermo A; Tuccinardi D; Minucci A; Capoluongo E; Pozzilli P; Manfrini S
    Hormones (Athens); 2018 Jun; 17(2):279-284. PubMed ID: 29860716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Case of 131I-meta-iodobenzylguanidine (MIBG) scintigraphy-negative and 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET)-positive pheochromocytoma].
    Jotoku M; Okura T; Nagao T; Enomoto D; Irita J; Miyoshi K; Kurata M; Fukuoka T; Higaki J
    Nihon Jinzo Gakkai Shi; 2009; 51(5):563-8. PubMed ID: 19715165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of 6-[18F]fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with von Hippel-Lindau syndrome.
    Kaji P; Carrasquillo JA; Linehan WM; Chen CC; Eisenhofer G; Pinto PA; Lai EW; Pacak K
    Eur J Endocrinol; 2007 Apr; 156(4):483-7. PubMed ID: 17389464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [11C]metahydroxyephedrine and [18F]fluorodeoxyglucose positron emission tomography improve clinical decision making in suspected pheochromocytoma.
    Mann GN; Link JM; Pham P; Pickett CA; Byrd DR; Kinahan PE; Krohn KA; Mankoff DA
    Ann Surg Oncol; 2006 Feb; 13(2):187-97. PubMed ID: 16418883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of normal and pathologic adrenal glands with 18F-FDOPA PET/CT: focus on pheochromocytomas.
    Moreau A; Giraudet AL; Kryza D; Borson-Chazot F; Bournaud C; Mognetti T; Lifante JC; Combemale P; Giammarile F; Houzard C
    Nucl Med Commun; 2017 Sep; 38(9):771-779. PubMed ID: 28704339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of 18F-FDOPA and 18F-FDG-PET in the management of malignant and multifocal phaeochromocytomas.
    Taïeb D; Tessonnier L; Sebag F; Niccoli-Sire P; Morange I; Colavolpe C; De Micco C; Barlier A; Palazzo FF; Henry JF; Mundler O
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):580-6. PubMed ID: 18394015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening in asymptomatic SDHx mutation carriers: added value of ¹⁸F-FDG PET/CT at initial diagnosis and 1-year follow-up.
    Lepoutre-Lussey C; Caramella C; Bidault F; Déandreis D; Berdelou A; Al Ghuzlan A; Hartl D; Borget I; Gimenez-Roqueplo AP; Dumont F; Deschamps F; Nascimento C; Lumbroso J; Guillaud Bataille M; Schlumberger M; Baudin E; Leboulleux S
    Eur J Nucl Med Mol Imaging; 2015 May; 42(6):868-76. PubMed ID: 25676472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-[F-18]Fluoro-L-dihydroxyphenylalanine positron emission tomography is superior to conventional imaging with (123)I-metaiodobenzylguanidine scintigraphy, computer tomography, and magnetic resonance imaging in localizing tumors causing catecholamine excess.
    Fiebrich HB; Brouwers AH; Kerstens MN; Pijl ME; Kema IP; de Jong JR; Jager PL; Elsinga PH; Dierckx RA; van der Wal JE; Sluiter WJ; de Vries EG; Links TP
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3922-30. PubMed ID: 19622618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic partial adrenalectomy for bilateral pheochromocytomas.
    Cheng SP; Saunders BD; Gauger PG; Doherty GM
    Ann Surg Oncol; 2008 Sep; 15(9):2506-8. PubMed ID: 18618188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (18)F-DOPA PET/CT and MRI: description of 12 histologically-verified pheochromocytomas.
    Magnaldi S; Mayerhoefer ME; Khameneh A; Schuetz M; Javor D; Mitterhauser M; Dudczak R; Hacker M; Karanikas G
    Anticancer Res; 2014 Feb; 34(2):791-5. PubMed ID: 24511014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early diagnosis of and surgical strategy for adrenal medullary disease in MEN II gene carriers.
    Jansson S; Tisell LE; Fjälling M; Lindberg S; Jacobsson L; Zachrisson BF
    Surgery; 1988 Jan; 103(1):11-8. PubMed ID: 2892276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic pulmonary pheochromocytomas: positive I-123 MIBG SPECT with negative I-131 MIBG and equivocal I-123 MIBG planar imaging.
    Tsuchimochi S; Nakajo M; Nakabeppu Y; Tani A
    Clin Nucl Med; 1997 Oct; 22(10):687-90. PubMed ID: 9343724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDOPA PET Compared With 123I-Metaiodobenzylguanidine Scintigraphy and 18F-FDG PET in Secreting Sporadic Pheochromocytoma.
    Lugat A; Drui D; Mirallié E; Kraeber-Bodéré F; Ansquer C
    Clin Nucl Med; 2019 Sep; 44(9):738-740. PubMed ID: 31306205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pheochromocytoma associated with adrenocortical tumor in the same gland. Two case reports and literature review.
    Cotesta D; Petramala L; Serra V; Giustini S; Divona L; Calvieri S; De Toma G; Ciardi A; Corsi A; Massa R; Reale MG; Letizia C
    Minerva Endocrinol; 2006 Jun; 31(2):183-9. PubMed ID: 16682942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrence of a Pheochromocytoma With TNEM127 Mutation Negative on 18F-FDOPA and 18F-FDG but Positive on 123I-MIBG and 68Ga-DOTATOC Imaging.
    Cottereau AS; Garcia C; Dousset B; Libe R; Tenenbaum F
    Clin Nucl Med; 2022 Mar; 47(3):251-252. PubMed ID: 34507330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. I-123 MIBG scintigraphy and 68Ga-DOTANOC PET/CT negative but F-18 DOPA PET/CT positive pheochromocytoma: a case report.
    Grassi I; Nanni C; Vicennati V; Castellucci P; Allegri V; Montini GC; Pagotto U; di Dalmazi G; Pasquali R; Fanti S
    Clin Nucl Med; 2011 Feb; 36(2):124-6. PubMed ID: 21220975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (18)F-DOPA PET/CT revealed synchronous neuroendocrine tumors in two sisters with MEN2A syndrome.
    Treglia G; Castaldi P; Rufini V
    Endocrine; 2013 Apr; 43(2):458-9. PubMed ID: 23229684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.